Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Learn how to automate your Git workflow and environment variables into a single, error-proof command that handles the boring stuff for you.